ACT-660602

• CAT Number: I042867
• CAS Number: 1646267-59-5
• Molecular Formula: C20H20F6N8OS
• Molecular Weight: 534.48
• Purity: ≥95%
• Synonyms: 2-(3,5-dimethyl-1,2,4-triazol-1-yl)-1-[(2R)-2-methyl-4-[2-(trifluoromethyl)-4-[2-(trifluoromethyl)pyrimidin-5-yl]-1,3-thiazol-5-yl]piperazin-1-yl]ethanone
• InChI: InChI=1S/C20H20F6N8OS/c1-10-8-32(4-5-33(10)14(35)9-34-12(3)29-11(2)31-34)16-15(30-18(36-16)20(24,25)26)13-6-27-17(28-7-13)19(21,22)23/h6-7,10H,4-5,8-9H2,1-3H3/t10-/m1/s1
• InChIKey: JENUMEXEVAAAJX-SNVBAGLBSA-N
• SMILES: C[C@@H]1CN(CCN1C(=O)CN2C(=NC(=N2)C)C)C3=C(N=C(S3)C(F)(F)F)C4=CN=C(N=C4)C(F)(F)F

ACT-660602（Cat No.:I042867）is a potent and selective inhibitor of the protein kinase CK2, which plays a critical role in cell signaling, cell survival, and proliferation. This compound is being investigated for its potential in cancer therapy, as CK2 is often overexpressed in various tumors and contributes to tumorigenesis. By inhibiting CK2 activity, ACT-660602 may help to disrupt cancer cell growth, induce apoptosis, and enhance the effectiveness of other anticancer treatments. Ongoing research focuses on evaluating its therapeutic potential, safety, and efficacy in the treatment of different cancers.